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Table 1
LOD Scores for Linkage of the Locus for the Autosomal Recessive
Form of Anhidrotic ED to Chromosome 2q11-q13 Markers
MARKER
LOD SCORE AT RECOMBINATION FRACTION OF
.00 .05 .10 .20 .30 . 40
D2S373  2.82 .94 .08 .09 .07
D2S293 7.40 6.86 5.78 4.14 2.53 1.04
D2S1890 5.81 5.39 4.57 3.30 2.04 .89
D2S160 6.33 5.84 4.97 3.59 2.24 .99
D2S121 .34 2.52 2.69 2.03 1.29 .58
D2S1895  2.89 3.34 2.57 1.61 .68
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Both Recessive and Dominant Forms of Anhidrotic/
Hypohidrotic Ectodermal Dysplasia Map to
Chromosome 2q11-q13
To the Editor:
Ectodermal dysplasias (EDs) are a group of conditions
characterized by the abnormal development of ecto-
dermal-derived structures including teeth, hair, and ec-
crine sweat glands. EDs may be either isolated or as-
sociated with other clinical manifestations. Hitherto,
1100 ED syndromes have been delineated (Freire-Maia
and Pinheiro 1988). Whereas the X-linked form of an-
hidrotic/hypohidrotic ED is well characterized (MIM
305100), the existence of autosomal dominant (MIM
129490) or recessive forms (MIM 224900) has long
been discussed. Partial resolution of this controversywas
provided when an autosomal dominant form of hypoh-
idrotic ED in a six-generation family was mapped to
chromosome 2q11-q13 (Ho et al. 1998). Clinical fea-
tures included smooth dry skin, hypotrichosis, decreased
sweating, and dental anomalies in most affected indi-
viduals in that family. The existence of autosomal re-
cessive anhidrotic/hypohidrotic ED is supported by the
occurrence of the disease in several families, including a
large inbred Moroccan kindred (Munoz et al. 1997;
Kabbaj et al. 1998). Here we show that a gene for au-
tosomal recessive ED maps to 2q11-q13, suggesting that
dominant and recessive ED may be allelic disorders.
In a large inbred Moroccan kindred, all 14 individuals
affected with autosomal recessive ED presented with hy-
potrichosis, hypodontia, and anhidrosis (Kabbaj et al.
1998). Six of the affected children died in early child-
hood, probably as a result of dehydration episodes. After
obtaining informed consent, we collected blood samples
from a total of 32 family members, including 8 affected
children. DNA was prepared by standard methods and
genotyping was done as reported elsewhere (Belin et al.
1998). After the exclusion of several chromosomal
regions encompassing candidate genes, we tested poly-
morphic markers in the chromosome 2q11-q13 region
in which a gene for dominant ED has been mapped (Ho
et al. 1998). LOD scores were computed with the LIPED
program, version 5.0, under the assumption of auto-
somal recessive inheritance with complete penetrance
and a disease allele frequency of .001 (Ott 1974). Pos-
itive two-point LOD scores were obtained with several
markers in the region 2q11-q13, with a maximum LOD
score of 7.4, at a recombination fraction of zero, with
D2S293 (table 1). The allele shared by all the patients
at D2S293 was not found on the normal chromosomes
of 11 obligatory ED carriers, which suggests the exis-
tence of a linkage disequilibrium.
A common haplotype between D2S113 and D2S2269
was identified in six of seven parents of the patients,
with an apparent ancestral recombination at the locus
D2S135 in individual 21 (fig. 1). Recombination events
were observed in patients 24, 25, and 44, at loci D2S373,
D2S1895, and D2S121, respectively, which made it pos-
sible to locate the disease locus in the 7.47-cM interval
between loci D2S135 and D2S121. In all the patients,
homozygosity for each of the markers was present in
this interval.
During the mapping of a gene for dominant ED, Ho
et al. (1998) found several discrepancies in the marker
order, throughout the 2q11-q13 region, between the
Marshfield genetic map and the Whitehead physical
YAC contig sequence-tagged site (STS) content map. In
their analyses, which were consistent with the marker
order in the Whitehead physical STS content map, they
delineated recombinant haplotypes and defined the
proximal flanking boundary for the gene for dominant
ED (ED3, previously known as “EDA3” [Ho et al.
1998]) at D2S1321 and the distal flanking boundary at
D2S308. This region entirely contains the interval in
which we mapped a gene for recessive ED (fig. 2).
The possibility that affected individuals might be ho-
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Figure 1 Haplotypes of the chromosome 2q11-q13 region of the patients and their parents. The haplotypes were inferred on the basis
of the analyses of additional family members examined but not shown. A complete pedigree of the family appears elsewhere (Kabbaj et al.
1998).
mozygous for a dominant allele with very mild expres-
sion in heterozygote carriers was considered. However,
the obligate carriers were reexamined and none of them
presented any sign of ED. Two main explanations can
account for the localization of dominant and recessive
ED to the same chromosomal region. First, one can hy-
pothesize that a cluster of genes with related function
maps to chromosome 2q11-q13. The existence of gene
clusters coding for related proteins such as collagens or
keratins is well known, and linked genes may encode
various subunits of a single multimeric complex. For
instance, mutations in either SUR1 or KIR6.2, which are
tightly linked genes on chromosome 11p15.1, result in
persistent hyperinsulinemic hypoglycemia of infancy. Al-
ternatively, autosomal recessive and dominant EDmight
be allelic disorders, as previously shown in several dis-
eases. For instance, collagen gene mutations may cause
either dominant or recessive disorders, depending on
their nature. Indeed, mutations in COL11A2 cause ei-
ther Stickler syndrome, a dominant disorder, or OS-
MED, a recessive bone dysplasia (Vikkula et al. 1995).
As mentioned by Ho et al. (1998), the candidate re-
gion contains several genes and anonymous expressed
sequences, none which seem to be reasonable candidates
by their function or by homology with mouse mutant
phenotypes. The study of additional families of both
recessive and dominant ED should allow reduction of
the interval, toward the cloning of the gene or genes
involved in these disorders.
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Mosaicism and Sporadic Familial Adenomatous
Polyposis
To the Editor:
Familial adenomatous polyposis (FAP [MIM 175100])
is an autosomal dominant heritable disorder caused
by germ-line mutations in the APC gene (M74088
[GenBank]). There is a high new-mutation rate, with
∼25% of all cases being sporadic (Bisgaard et al. 1994).
Parental mosaicism can explain newmutations in genetic
disorders (Hall 1988), whereas germ-line and/or somatic
mosaicism has been described in genes associated with
tumors such as p53 (Kovar et al. 1992), Rb1 (Greger et
al. 1990; Lohmann et al. 1997), NF1 (La´zaro et al.
1995), and NF2 (Bourn et al. 1994). We were interested
to determine whether APC-gene mutational mosaicism
could account for some of the apparentlynew” APCmu-
tations. Systematic studies of our registry identified five
in which a germ-line mutation was established (Prosser
et al. 1994), parental leukocyte DNA was available, and
paternity was assured. These five patients were the sub-
jects of detailed studies to determine the level of parental
APC mutational mosaicism (table 1).
During S35 sequencing of parental blood-leukocyte
DNA samples from the first sporadic FAP case, we noted
a faint mutant allele that was reproducible on repeated
analyses. The clinical history of this sporadic FAP patient
(patient 17) is noteworthy. Dense distal colonic poly-
posis was diagnosed at age 22 years, with three distinct
carcinomas and myriads of smaller polyps, many of
which showed carcinomatous change. Mastectomy was
required for breast carcinoma when the patient was age
37 years, and disseminated ovarian cancer resulted in
death at age 44 years. Her mother (patient 16) had a
mastectomy for breast carcinoma at age 46 years, was
negative in a screen for colonic polyps when she was
